Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Social Determinants, Including Racism, Are Major Drivers of Health Inequity, Watson Says
July 31st 2022Social determinants of health are major drivers of the inequities seen in health outcomes, and racism is clearly a social determinant tied to life expectancy, said Karol Watson, MD, PhD, in talk Sunday at the 2022 Congress of the American Society for Preventive Cardiology, held in Louisville, Kentucky.
Read More
Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV Care
July 30th 2022Ty J. Gluckman, MD, FACC, FAHA, who is medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, addressed the 2022 Congress of the American Society for Preventive Cardiology meeting in Louisville, Kentucky.
Read More
Duke’s Douglas Highlights Need for Respect in Promoting Diversity, Health Equity
July 30th 2022Duke University’s Pamela S. Douglas, MD, spoke to cardiology professionals who gathered for the start of the 2022 Congress of the American Society for Preventive Cardiology (ASPC), in Louisville, Kentucky.
Read More
Early Use of Novel Therapies in Multiple Myeloma Could Target Bone Marrow Microenvironment
July 28th 2022Authors explained how multiple myeloma emerges from earlier clinical phases and the tumor’s microenvironment in the early course of the disease plays a critical role in the survival of myeloma cells.
Read More
After Transplant, City of Hope Patient in Long-term Remission From HIV and Leukemia
July 27th 2022City of Hope has announced that a patient living with HIV, who received a stem cell transplant from an unrelated donor to treat acute myelogenous leukemia, has been in remission from both diseases since 2019.
Read More
Ravi B. Parikh, MD, MPP, assistant professor, Department of Medical Ethics and Health Policy and Medicine, Perelman School of Medicine, University of Pennsylvania, presented long-term results from an experiment with an algorithm designed to prompt oncologists to have serious illness conversations.
Read More
Dr Anne McCall Discusses How Louisiana’s History Will Shape Xavier/Takeda Partnership
July 21st 2022In part 2 of our interview with Anne McCall, PhD, provost and senior vice president for academic affairs at Xavier University of Louisiana, she discusses in greater detail the university’s 3-year partnership with Takeda, in particular how the directions it goes in will be influenced by the history of unequal health care delivery in the state.
Read More
ASCO Spotlight With Randall A. Oyer, MD: Clinical Trials Must Be Accessible to Everyone
July 21st 2022Randall A. Oyer, MD, medical director of the Ann B. Barshinger Cancer Institute, medical director of oncology, and medical director of the Cancer Risk Evaluation Program, Lancaster General Health, discusses recommendations to improve diversity in clinical trials.
Read More
Survey Finds Shift in Clinician Views of MRD Status in Treatment Decisions for Multiple Myeloma
July 16th 2022Results looking at acceptance of minimal residual disease (MRD) status found that 60% of participants “would change at least one decision based on an MRD result,” and 54% would use both MRD status and disease risk to make decisions.
Read More
Lessons Learned in New Orleans Can Be Shared Across the US, Powell Says
July 12th 2022This the third installment of a series of interviews on Takeda’s partnership with Xavier University of Louisiana (T-REX), Takeda's Lauren Powell, MPA, PhD, discussed the impact Louisiana's hospital system has had on her work and the need for the pharmaceutical industry to invest in more partnerships like T-REX.
Read More
Dr Lauren Powell: Takeda’s Partnership With Xavier Is a Long-term Investment
July 8th 2022In the second interview in a series, Takeda’s Lauren Powell, MPA, PhD, vice president, US Health Equity & Community Wellness, discussed how a partnership with Xavier University of Louisiana will unfold over several years.
Read More
Researchers From Spain Find Option to Detect FGFR2 Fusion in Plasma
July 2nd 2022Vall d'Hebron Institute of Oncology, a research group from Barcelona, Spain, has presented a method to detect FGFR2 fusion in plasma, which they say is “especially relevant” since the arrival of pemigatinib to treat patients with recurrent intrahepatic cholangiocarcinoma (iCCA).
Read More
FCS’ Walcker Outlines His Hopes for Successor Model to OCM
July 1st 2022In the second of 2 parts, Nathan H. Walcker, MBA, CEO of Florida Cancer Specialists & Research Institute (FCS), discusses what he’d like value-based care to look like going forward. CMS ended the Oncology Care Model (OCM) yesterday after 6 years and has invited practices to apply for a successor model, the Enhancing Oncology Model.
Read More
FCS’ Walcker Explains Value-Based Cancer Care
June 30th 2022In the first of 2 parts, Nathan H. Walcker, MBA, CEO of Florida Cancer Specialists & Research Institute (FCS), discusses the future of value-based care for the practice as the Oncology Care Model comes to an end today. This week, CMS announced it will launch a successor model.
Read More
CMS Announces OCM Successor, but Gap Year Remains for Oncology Practices
June 27th 2022Today, CMS unveiled its plan for a successor to the Oncology Care Model (OCM), its ambitious foray into value-based care delivery that has been credited with changing the landscape for patients with cancer, even if it received mixed reviews on achieving savings in its early years.
Read More
Thyme Care: A Human Touch in Cancer Care, Guided by Technology
June 23rd 2022Oncologist and health tech veteran Bobby Green, MD, who practiced for 17 years in Florida and was previously with Flatiron, is now Thyme Care’s president and chief medical officer. He has relocated to Nashville, Tennessee, to launch Thyme Care.
Read More